Tvardi Therapeutics (TVRD) Cash from Investing Activities (2016 - 2025)
Tvardi Therapeutics' Cash from Investing Activities history spans 13 years, with the latest figure at $5.0 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities changed 0.0% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a 63.38% decrease, with the full-year FY2025 number at -$10.1 million, down 120.69% from a year prior.
- Cash from Investing Activities hit $5.0 million in Q4 2025 for Tvardi Therapeutics, down from $5.3 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for TVRD hit a ceiling of $44.4 million in Q4 2022 and a floor of -$53.6 million in Q4 2021.
- Historically, Cash from Investing Activities has averaged $12.6 million across 5 years, with a median of $16.5 million in 2023.
- Biggest five-year swings in Cash from Investing Activities: soared 182.91% in 2022 and later plummeted 167.99% in 2023.
- Tracing TVRD's Cash from Investing Activities over 5 years: stood at -$53.6 million in 2021, then soared by 182.91% to $44.4 million in 2022, then plummeted by 167.99% to -$30.2 million in 2023, then soared by 116.55% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
- Business Quant data shows Cash from Investing Activities for TVRD at $5.0 million in Q4 2025, $5.3 million in Q3 2025, and $5.0 million in Q4 2024.